通过先进的机器学习模型评估乳腺癌中端粒酶特征的预后潜力
Xiao Guo1, Yuyan Cao1, Xinlin Shi1
1School of Pharmacy, Beihua University, Jilin, Jilin, China.
Frontiers in immunology
|December 13, 2024
概括
一个新的机器学习辅助的端粒酶签名 (MLTS) 改善了乳腺癌预后预测. 这种端粒酶签名能够准确地识别高风险患者,并有助于开发个性化疗法.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 由于分子异质性,乳腺癌的预后具有挑战性.
- 准确的预测模型对于个性化治疗策略至关重要.
研究的目的:
- 开发和验证一种新的乳腺癌预后生物标志物.
- 整合多omics数据,以提高预测准确度.
主要方法:
- 开发了一种机器学习辅助的端粒酶签名 (MLTS),使用来自九个乳腺癌数据集的多omics数据.
- 通过机器学习算法识别了与患者存活相关的六个关键端粒酶相关基因.
- 评估了与66个现有的预后模型相对应的MLTS性能.
主要成果:
- 与现有模型相比,MLTS表现出卓越的预测准确性,稳定性和可靠性.
- 高MLTS得分与增加的瘤突变负担,染色体不稳定性和较差的生存率相关.
- 在无体瘤细胞中,MLTS得分更高,并且与瘤微环境特征相关.
结论:
- MLTS作为乳腺癌的强有力的预后生物标志物.
- 针对个性化治疗的MLTS潜力得到了其与基因组和细胞特征的关联的支持.
- 未来的研究可能将MLTS与其他分子签名集成为临床精确瘤学应用.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


